IriSys

IriSys provides contract pharmaceutical product development and manufacturing services. They offer a full spectrum of pharmaceutical product development contract services, from early research to Phase I/II clinical trials. Acquired by Recro®, IriSys excels in delivering a wide range of solutions tailored to meet the complexities of the pharmaceutical industry.

Services include:
- Accelerated Stability Studies
- Analytical Services
- Aseptic Fill/Finish
- cGMP Synthesis
- Clinical Trials
- Consulting
- Regulatory
- Custom Synthesis
- Efficacy Testing
- Filling
- Cartridge
- Syringe
- IND/NDA Submissions
- Manufacturing
- Aseptic Fill-Finish
- Capsule
- Clinical Trial Materials
- Creams & Ointments
- Dose Form
- Non-Sterile
- Sterile
- Ethical
- Gels
- Inhalables
- Liquids
- Microbial-based Therapeutic Proteins
- Nutraceuticals
- Ophthalmics
- Oral Drug Delivery
- OTC
- Parenterals
- Small Volume
- Peptides
- Powders
- Proteins
- Soft Gels
- Solid Dosage
- Suppositories
- Sustained Release
- Tablets
- Topicals
- Animal Health
- Packaging
- Anti-Counterfeiting
- Banding
- Blister
- Cold Form
- Closures
- Compliance
- Electronic Pedigree
- Glass
- Labelling
- Pouches
- Samples
- Spray Pumps
- Tubes
- Parenterals Development
- Ampule
- Vials
- Preclinical Study Design
- Process R&D
- R&D Services
- Serialization
- Stability Studies
- Statistical Analysis
- Sterility Testing
- Sterilization
- Primary Packaging Materials
- Tablet Coating
- Tablet Punches and Dies
- Trays
- Soft Gel Drying
- Validation

IriSys is recognised for its commitment to quality and client satisfaction within the pharmaceutical sector. For more information, please visit irisys.com.